NeuroSigma Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 5

NeuroSigma General Information

Description

Developer of bioelectronic medical technology intended for neurological disorder treatment. The company's neuromodulation therapies utilize a self-adhesive conductive pad applied to the forehead to stimulate branches of the trigeminal nerve, which are located very close to the surface of the skin of the forehead, enabling patients to recover from epilepsy, depression, post-traumatic stress disorder, and attention-deficit hyperactivity disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10960 Wilshire Boulevard
  • Suite 1910
  • Los Angeles, CA 90024
  • United States
+1 (310)
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Therapeutic Devices
Vertical(s)
Corporate Office
  • 10960 Wilshire Boulevard
  • Suite 1910
  • Los Angeles, CA 90024
  • United States
+1 (310)

NeuroSigma Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroSigma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 09-May-2024 Completed Generating Revenue
6. Later Stage VC 08-Dec-2021 Completed Generating Revenue
5. Grant 01-Jan-2016 Completed Generating Revenue
4. Grant 01-Jan-2013 Completed Generating Revenue
3. Grant 04-Sep-2012 Completed Generating Revenue
2. Seed Round 10-Mar-2011 $1.21M $1.21M Completed Generating Revenue
1. University Spin-Out 01-Jan-2008 Completed Startup
To view NeuroSigma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NeuroSigma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bioelectronic medical technology intended for neurological disorder treatment. The company's neuromodulatio
Other Devices and Supplies
Los Angeles, CA
8 As of 2024

Helsinki, Finland
 

Milan, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeuroSigma Competitors (2)

One of NeuroSigma’s 2 competitors is Sooma, a Venture Capital-Backed company based in Helsinki, Finland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sooma Venture Capital-Backed Helsinki, Finland
Newronika Venture Capital-Backed Milan, Italy
You’re viewing 2 of 2 competitors. Get the full list »

NeuroSigma Patents

NeuroSigma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3186187-A1 Pulse generator for trigeminal nerve stimulation Pending 17-Jul-2020
EP-4182005-A1 Pulse generator for trigeminal nerve stimulation Pending 17-Jul-2020
US-20230270995-A1 Pulse generator for trigeminal nerve stimulation Pending 17-Jul-2020
EP-4182005-A4 Pulse generator for trigeminal nerve stimulation Pending 17-Jul-2020
US-10537729-B2 Trigeminal neurostimulation based upon pulse counting and chronobiology Active 19-Nov-2014 A61N1/0456
To view NeuroSigma’s complete patent history, request access »

NeuroSigma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroSigma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
KidsX Accelerator Accelerator/Incubator
Checkmate Capital Group Venture Capital Minority
KT Corporation Minority
National Institutes of Neurological Disorders and Stroke Government
University of California, Los Angeles University
To view NeuroSigma’s complete investors history, request access »

NeuroSigma FAQs

  • When was NeuroSigma founded?

    NeuroSigma was founded in 2008.

  • Where is NeuroSigma headquartered?

    NeuroSigma is headquartered in Los Angeles, CA.

  • What is the size of NeuroSigma?

    NeuroSigma has 8 total employees.

  • What industry is NeuroSigma in?

    NeuroSigma’s primary industry is Other Devices and Supplies.

  • Is NeuroSigma a private or public company?

    NeuroSigma is a Private company.

  • What is NeuroSigma’s current revenue?

    The current revenue for NeuroSigma is .

  • How much funding has NeuroSigma raised over time?

    NeuroSigma has raised $17.9M.

  • Who are NeuroSigma’s investors?

    KidsX Accelerator, Checkmate Capital Group, KT, National Institutes of Neurological Disorders and Stroke, and University of California, Los Angeles have invested in NeuroSigma.

  • Who are NeuroSigma’s competitors?

    Sooma and Newronika are competitors of NeuroSigma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »